Penn Medicine: New Therapy Treats Autoimmune Disease Without Harming Normal Immunity

In a study with potentially major implications for the future treatment of autoimmunity and related conditions, scientists from the Perelman School of Medicine at the University of Pennsylvania have found a way to remove the subset of antibody-making cells that cause an autoimmune disease, without harming the rest of the immune system.

Karen Kreeger

Penn Study: New Antiviral Drugs Could Come From DNA ‘Scrunching’

Evidence of DNA “scrunching” may one day lead to a new class of drugs against viruses, according to a research team from the Perelman School of Medicine at the University of Pennsylvania, the Georgia Institute of Technology, and Columbia University. The team is led by Stephen C.

Karen Kreeger